View GHK-CU Certificate of Analysis COA of BPC-157 COA of TB500 Why Choose the GLOW Stack? The GLOW stack is a specialized three-peptide research blend that combines GHK-Cu, BPC-157, and TB-500 in a single lyophilized vial . This formulation is often studied for its multi-pathway approach to tissue repair, collagen synthesis, and recovery research. The name “GLOW” reflects the blend’s association with skin health, tissue regeneration, and overall vitality research . The typical 70mg GLOW vial comprises 50mg of GHK-Cu, 10mg of BPC-157, and 10mg of TB-500, though formulations can vary by supplier . Understanding the distinct backgrounds and mechanisms of each component provides important context for researchers. The History & Origins GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding peptide first identified in human plasma in the 1970s . It is a tripeptide composed of glycine, histidine, and lysine, complexed with copper ions. Its discovery marked a significant milestone in skin science and wound healing research, and it has been studied for decades for its role in dermal remodeling and tissue repair . BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protective protein found in gastric juice. First characterized in the 1990s, this 15-amino-acid sequence was isolated from gastric mucosal extracts and has demonstrated remarkable stability across different biological environments . TB-500 is a synthetic analogue of thymosin beta-4, a naturally occurring 43-amino-acid polypeptide found in virtually all human and animal cells . This peptide is highly conserved across species and plays fundamental roles in cellular differentiation, tissue remodeling, and wound healing processes. The TB-500 fragment corresponds to the active region of thymosin beta-4, specifically amino acids 17-23 . How They Work: Distinct But Complementary While these three peptides are often studied together in the GLOW stack, each operates through distinct biological pathways that address different aspects of tissue repair and regeneration . GHK-Cu Research Mechanisms Binds to copper and delivers it to tissues, acting as an essential cofactor for enzymatic processes involved in wound healing and collagen synthesis Stimulates collagen and glycosaminoglycan production, critical for skin structure and elasticity research Exhibits antioxidant properties and has been shown to modulate gene expression associated with tissue remodeling Supports wound healing and cellular repair mechanisms BPC-157 Research Mechanisms Modulates angiogenesis through upregulation of vascular endothelial growth factor (VEGF) expression Influences nitric oxide synthase activity, affecting vascular tone and tissue perfusion Exhibits anti-inflammatory properties through modulation of pro-inflammatory cytokine production Promotes blood vessel formation and supports collagen production pathways TB-500 Research Mechanisms Regulates actin dynamics—binding to G-actin to facilitate cellular migration essential for wound healing Demonstrates potent angiogenic properties through endothelial cell migration and proliferation Modulates inflammatory responses and promotes resolution pathways Exhibits anti-inflammatory and tissue regeneration properties in preclinical studies The Synergistic Potential Researchers often study these peptides together because their mechanisms are complementary rather than duplicative: GHK-Cu is frequently examined for its effects on skin tissue, collagen remodeling, and dermal regeneration—addressing the aesthetic and structural aspects of tissue health . BPC-157 is associated with localized tissue repair—tendon and ligament structures, gastrointestinal tissue, and muscle-tendon junctions—focusing on vascular signaling and inflammatory modulation . TB-500 is associated with systemic effects—influencing cytoskeletal behavior, cell migration dynamics, and structural remodeling across multiple tissues . Together, they represent a multi-pathway approach to tissue repair research: GHK-Cu addressing collagen and skin remodeling, BPC-157 focusing on vascular signaling and localized repair, while TB-500 addresses cellular movement and systemic structural organization Laboratory research compound evaluated in controlled preclinical settings. Intended strictly for laboratory and educational research applications. For research use only. Restricted to in vitro laboratory experimentation and cannot be: Used in clinical or investigational studies
Related products
